Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Advances in Hematology & Oncology : H&O|March 24, 2016
Current Options for Third-Line Treatment of Metastatic Colorectal CancerAxel Grothey, John L Marshall, Tara E SeeryCancer Chemotherapy and Pharmacology|June 23, 2009
Temozolomide in malignant gliomas: current use and future targetsJ Lee Villano, Tara E Seery, Linda R BresslerClinical and Molecular Hepatology|July 18, 2014
Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenibJoon-Il Choi, David K Imagawa, Priya Bhosale, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 18, 2012
Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancerTara E Seery, Argyrios Ziogas, Bruce S Lin, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 4, 2013
Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysisWalter Y Tsang, Argyrios Ziogas, Bruce S Lin, et al.Cancer|April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.JAMA Oncology|December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical TrialVincent Chung, Shannon McDonough, Philip A Philip, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaSunil R Hingorani, Lei Zheng, Andrea J Bullock, et al.Pageof 1